Suppr超能文献

固体转化为液体——用于提高药物溶解度的药剂学液体共晶体系

Solids Turn into Liquids-Liquid Eutectic Systems of Pharmaceutics to Improve Drug Solubility.

作者信息

Sarraguça Mafalda C, Ribeiro Paulo R S, Nunes Cláudia, Seabra Catarina Leal

机构信息

LAQV-REQUIMTE, Faculdade de Farmácia, Universidade do Porto, Rua de Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal.

Centro de Ciências Sociais, Saúde e Tecnologia, Universidade Federal do Maranhão, Imperatriz 65900-410, Brazil.

出版信息

Pharmaceuticals (Basel). 2022 Feb 23;15(3):279. doi: 10.3390/ph15030279.

Abstract

The low solubility of active pharmaceutical ingredients (APIs) is a problem in pharmaceutical development. Several methodologies can be used to improve API solubility, including the use of eutectic systems in which one of the constituents is the API. This class of compounds is commonly called Therapeutic Deep Eutectic Systems (THEDES). THEDES has been gaining attention due to their properties such as non-toxicity, biodegradability, and being non-expensive and easy to prepare. Since the knowledge of the solid liquid diagram of the mixture and the ideal eutectic point is necessary to ascertain if a mixture is a deep eutectic or just a eutectic mixture that is liquid at ambient temperature, the systems studied in this work are called Therapeutic Liquid Eutectic Systems (THELES). Therefore, the strategy proposed in this work is to improve the solubility of chlorpropamide and tolbutamide by preparing THELES. Both APIs are sulfonylurea compounds used for the treatment of type 2 diabetes mellitus and have low solubility in water. To prepare the THELES, several coformers were tested, namely, tromethamine, L(+)-arginine, L-tryptophan, citric acid, malic acid, ascorbic acid, and -aminobenzoic acid, in molar ratios of 1:1 and 1:2. To improve viscosity, water was added in different molar ratios to all systems. THELES were characterized by mid-infrared spectroscopy (MIR), and differential scanning calorimetry. Their viscosity, solubility, and permeability were also determined. Their stability at room temperature and 40 °C was accessed by MIR. Cytocompatibility was performed by metabolic activity and cell lysis evaluation, according to ISO10993-5:2009, and compared with the crystalline APIs. THELES with TRIS were successfully synthesized for both APIs. Results showed an increased solubility without a decrease in the permeability of the APIs in the THELES when compared with the pure APIs. The THELES were also considered stable for 8 weeks at ambient temperature. The cells studied showed that the THELES were not toxic for the cell lines used.

摘要

活性药物成分(API)的低溶解度是药物研发中的一个问题。有几种方法可用于提高API的溶解度,包括使用共晶体系,其中一种成分是API。这类化合物通常被称为治疗性低共熔体系(THEDES)。THEDES因其无毒、可生物降解、价格低廉且易于制备等特性而受到关注。由于确定混合物是深共熔体系还是仅为在室温下呈液态的共熔混合物需要了解混合物的固液相图和理想共熔点,因此本研究中所研究的体系被称为治疗性液态共熔体系(THELES)。所以,本研究提出的策略是通过制备THELES来提高氯磺丙脲和甲苯磺丁脲的溶解度。这两种API都是用于治疗2型糖尿病的磺脲类化合物,在水中溶解度较低。为了制备THELES,测试了几种共形成剂,即三羟甲基氨基甲烷、L(+)-精氨酸、L-色氨酸、柠檬酸、苹果酸、抗坏血酸和对氨基苯甲酸,摩尔比为1:1和1:2。为了提高粘度,以不同摩尔比向所有体系中添加水。通过中红外光谱(MIR)和差示扫描量热法对THELES进行了表征。还测定了它们的粘度、溶解度和渗透率。通过MIR评估了它们在室温及40℃下的稳定性。根据ISO10993-5:2009,通过代谢活性和细胞裂解评估进行细胞相容性测试,并与结晶API进行比较。两种API都成功合成了含TRIS的THELES。结果表明,与纯API相比,THELES中API的溶解度增加,而渗透率没有降低。THELES在室温下也被认为在8周内是稳定的。所研究的细胞表明,THELES对所用细胞系无毒。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/769e/8951776/3664b0e51c0f/pharmaceuticals-15-00279-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验